XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode

Publications

Licensing and supervision

Side effects and product information

Reimbursement and prices

Pharmacies and sale of medicines

Medical devices

About us

Show by date

  • Annual report 2009 of the Danish Medicines Agency's laboratory control activities

    | 14 June 2010 |

    The medical authorities in Europe cooperate in a network called the Official Medicines Control Laboratories (OMCL). The Danish Medicines Agency has published an annual report for 2009 that d

  • Annual report on human tissues and cells 2009

    | 01 November 2010 |

    The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establishments and gynaecology clinics in Denmark in the period January to December 2009.

  • Annual report on human tissues and cells 2008

    | 05 March 2010 |

    The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establisments and gynaecology clinics in Denmark in the period January to December 2008

  • Annual report of the Reimbursement Committee 2009

    | 23 April 2010 |

    Members appointed by the Danish Minister for the Interior and Health 17 meetings in 2009 21 applications for general reimbursement Grounds 1632 applications for individual reimbursement Annual

  • Danish Medicines Agency’s annual pharmacovigilance report 2009

    | 29 March 2010 |

    The annual report offers an insight into the pharmacovigilance work performed by the Danish Medicines Agency in 2009.

  • Performance contract 2008

    | 19 December 2008 |

  • Report on the blood product area in 2007

    | 13 October 2008 |

    The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.

  • Product defects and withdrawal of medicinal products in 2007

    | 19 May 2008 |

    In 2007, 202 reports about medicinal product defects were registered, which is basically on level with 2006. 28 % of these reports resulted in a withdrawal from the Danish market, which is exactly the same proportion as the year before.

  • Survey of pharmaceutical companies' satisfaction with the Danish Medicines Agency

    | 19 September 2008 |

    The research company Capacent Epinion has asked pharmaceutical companies to indicate their level of satisfaction with the Danish Medicines Agency. A total of 40 companies participated in the survey, which was carried out in May to June 2008.

  • Danish Medicines Agency annual accounts 2007

    | 22 April 2008 |

    In 2007, the Danish Medicines Agency achieved a target performance of 93.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of three in every four sub-requirements. Overall, we assess that we delivered good technical results in 2007, among other things, based on the fact that the most strategically important performance requirements were fulfilled.

  • Danish Medicines Agency annual report 2007

    | 10 September 2008 |

    The annual report 2007 takes you through important activities within the Danish Medicines Agency in 2007. On a number of theme pages, we also tell about projects that strengthen our cooperation with the business sector, our relations to consumers and our involvement in European development.

  • Report on action against the sale of illegal medicinal products on the internet 2007

    | 03 December 2007 |

    In September and October 2007, the Danish Medicines Agency launched an internet action against illegal medicinal products sold on the internet. The action was targeted at 86 products classified

  • Investigation of pharmacy discounts

    | 09 February 2007 |

    Based on an approach from the Danish Association of the Pharmaceutical Industry (Lif) in February 2006, the Ministry of the Interior and Health requested the Danish Medicines Agency to investigate whether any new discount arrangements were introduced in 2006 contrary to the rules in that area.

  • Danes' buying of medicine on the internet and abroad – survey

    | 11 September 2007 |

    A recent survey conducted by the Danish Medicines Agency maintains that there is limited knowledge among the Danish people about the rules applicable to and the risks associated with buying medicine on the internet and abroad.

  • Applications for individual reimbursement of medicinal products in 2006

    | 12 April 2007 |

    In 2006, the Danish Medicines Agency reviewed some 106.700 applications for single reimbursement (down 4% on 2005), apporx. 14.600 applications for reimbursement for the chronically ill (down 37 % on 2005), approx. 9.200 applications for reimbursement for the terminally ill (same level as in 2005) and approx. 2.700 applications for increased reimbursement (same level as in 2005, cf. table 1 below).

  • Danish Medicines Agency annual accounts 2006

    | 17 April 2007 |

    The Danish Medicines Agency's performance contract with the Ministry of the Interior and Health for 2006 comprises 12 targets made up of 28 performance requirements and 58 sub-requirements. Furthermore, the performance contract includes one focus area.

  • Danish Medicines Agency annual report 2006

    | 12 September 2007 |

    In the report for 2006, we have chosen to bring you samples of how we put our values into practice in our daily activities. Read more about how we have been competent, trustworthy, attentive, receptive and European from the fact box to the right.

  • Performance contract 2009

    | 03 July 2009 |

    The Danish Medicines Agency and the Ministry of Health and Prevention have agreed upon a performance contract, which is valid for 2009. The contract, which is in Danish only, focuses on external targets that cover the Danish Medicines Agency's tasks to the greatest extent possible.

  • Product defects and withdrawal of medicinal products in 2008

    | 16 April 2009 |

    In 2008, 177 reports of medicinal product defects were registered, which is less than in 2007. 23 % of these reports led to products being withdrawn from the market, which is also less than in the preceding years. Most of the withdrawals effected in 2008 were occasioned by reports made by the companies.

  • Danish Medicines Agency annual accounts 2008

    | 17 April 2009 |

    In 2008, the Danish Medicines Agency achieved a target performance of 91.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of four in every five sub-requirements. Overall, we find that we delivered good technical results in 2008.

Related content